This inventor holds 25 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Sanofi, Sanofi-Synthelabo, Sanofi-Aventis. Active years: 1988-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- St-Gely-du-Fesc, FR (1989 - 1997)
- St. Gely Du Fesc, FR (1997)
- Saint-Gely-du-Fesc, FR (1988 - 1998)
- Frontignan, FR (1999 - 2007)
Company Filing History:
19 out of 1,562 
3 out of 152 
2 out of 390 
Years Active: 1988-2007
Areas of Expertise:
Title: Innovations and Contributions of Georges Garcia in Therapeutic Research
Introduction
Georges Garcia, located in Saint Gely du Fesc, France, is a noteworthy inventor with an impressive portfolio of 25 patents. His work focuses on the development of novel therapeutic compounds that have the potential to advance medical treatments.
Latest Patents
Among Georges Garcia's most recent patents is his innovative work on acyloxypyrrolidine derivatives, which involves their preparation and therapeutic applications. These derivatives are proposed to have significant implications in the field of medicine. Another notable patent involves phenylsulfonyl-1,3-dihydro-2H-indole-2-one derivatives, detailing their preparation and therapeutic use. This invention encompasses compounds that show affinity and selectivity for the arginine-vasopressin V receptors and oxytocin receptors. Furthermore, this patent covers the processes for preparing these compounds, including their intermediate forms and pharmaceutical compositions, which can be utilized to develop medicinal products.
Career Highlights
Georges Garcia has made considerable strides in his career by being associated with renowned companies such as Sanofi and Sanofi-Synthelabo. His experience in these organizations has been instrumental in shaping his research and development capabilities, focusing on innovative therapeutic solutions.
Collaborations
Throughout his professional journey, Georges has collaborated with esteemed colleagues including Richard Roux and Dino Nisato. These partnerships have likely enriched the research outcomes and fostered an environment of shared knowledge and expertise within the pharmaceutical industry.
Conclusion
Georges Garcia stands out as an innovative inventor whose work continues to influence therapeutic research. His extensive patent portfolio highlights his commitment to advancing medical science, and his collaborations reflect a strong network of professionals dedicated to innovation in the pharmaceutical field. The impact of his inventions is seen in the potential benefits they could bring to medical treatments, showcasing the importance of his contributions to science and healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile